Regulatory B cells are significantly reduced in AQP-4 positive patients compared to MS patients, possibly due to the high IL6 secretion, which subsequently inhibits the generation of regulatory B cells (Quan et al., 2013). This evidence concerns the gene IL6 and myeloid sarcoma.